China Biologic Products (CBPO) in Focus: Stock Plunges 11.4%

China Biologic Products, Inc. (CBPO) saw a big move last session, as the company’s shares fell by over 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for CBPO, as the stock is now up nearly 6% since May 21.

The plasma-based biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past week and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

CBPO currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Biomedical industry include ANI Pharmaceuticals, Inc. (ANIP), Gilead Sciences Inc. (GILD) and Illumina Inc. (ILMN). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






CHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report


Zacks Investment Research

Advertisement